These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The future of inotropic drugs in clinical practice. Smith TW Eur Heart J; 1982 Dec; 3 Suppl D():149-56. PubMed ID: 6130948 [No Abstract] [Full Text] [Related]
3. Digitalis in cardiac failure. Do benefits justify risks? Selzer A Arch Intern Med; 1981 Jan; 141(1):18-9. PubMed ID: 7447579 [No Abstract] [Full Text] [Related]
4. Inotropic drugs for treatment of the failing heart. Maskin CS; Le Jemtel TH; Sonnenblick EH Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040 [No Abstract] [Full Text] [Related]
5. The role of digitalis in the treatment of heart failure. Demers C; McKelvie RS; Yusuf S Coron Artery Dis; 1999 Sep; 10(6):353-60. PubMed ID: 10474784 [TBL] [Abstract][Full Text] [Related]
7. Clinical and circulatory aspects of digitalis in heart failure. Storstein L Eur Heart J; 1982 Dec; 3 Suppl D():59-64. PubMed ID: 6761128 [No Abstract] [Full Text] [Related]
8. Inotropic drugs in the management of congestive heart failure. Skelton CL J La State Med Soc; 1979 Apr; 131(4):109-17. PubMed ID: 458229 [No Abstract] [Full Text] [Related]
9. [The importance of cardiac glycoside therapy. Digitalis--to use or not to use?]. Jerie P Ther Umsch; 1984 Feb; 41(2):96-102. PubMed ID: 6369617 [No Abstract] [Full Text] [Related]
10. [Positive inotropic agents in the treatment of congestive heart failure]. Hori M; Tamai J; Inoue M Kokyu To Junkan; 1987 Mar; 35(3):261-7. PubMed ID: 3296067 [No Abstract] [Full Text] [Related]
11. [Inotropic agents: why yes and why not]. Ferrari M; Magnolfi G; Piovan D; Bertagna E Cardiologia; 1996 Sep; 41(9):831-41. PubMed ID: 8983841 [No Abstract] [Full Text] [Related]
12. [Digitalis in heart failure--still a therapeutic principle of current interest?]. Manhenke CA; Dickstein K Tidsskr Nor Laegeforen; 2001 Jan; 121(2):212-4. PubMed ID: 11475203 [No Abstract] [Full Text] [Related]
13. [Positive inotropic agents in heart failure. Clinico-pharmacological evidence for medical practice]. Rohde LE; Ribeiro JP Arq Bras Cardiol; 1994 Dec; 63(6):537-42. PubMed ID: 7605243 [No Abstract] [Full Text] [Related]
15. [Are cardiac glycosides still needed in the treatment of cardiac insufficiency?]. Böhm M Dtsch Med Wochenschr; 2002 Oct; 127(41):2133-8. PubMed ID: 12397560 [No Abstract] [Full Text] [Related]
17. Cardiac glycosides in the next millennium. Hauptman PJ; Garg R; Kelly RA Prog Cardiovasc Dis; 1999; 41(4):247-54. PubMed ID: 10362347 [TBL] [Abstract][Full Text] [Related]
18. [Modern evaluations of the activity of inotropic agents]. Dalla Volta S G Ital Cardiol; 1986 Mar; 16(3):250-1. PubMed ID: 2942435 [No Abstract] [Full Text] [Related]
19. [Digitalis and sinus rhythm. An old question that is still current]. Bobbio M G Ital Cardiol; 1986 Mar; 16(3):241-9. PubMed ID: 3525303 [TBL] [Abstract][Full Text] [Related]
20. Special concerns of digitalis use in elderly patients. Roffman DS Geriatrics; 1984 Jun; 39(6):97-8, 103-5. PubMed ID: 6724308 [No Abstract] [Full Text] [Related] [Next] [New Search]